Liquidia (LQDA) Amortization of Deferred Charges (2020 - 2021)

Liquidia (LQDA) recorded quarterly Amortization of Deferred Charges of $24166.0 in Q4 2021, down 68.94% quarter-over-quarter from $77816.0 in Q3 2021, and up 69.69% on a YoY basis from $14241.0 in Q4 2020.

Liquidia (LQDA) Amortization of Deferred Charges (2020 - 2021) Analysis & Trends

Liquidia's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $24166.0 for Q4 2021.

  • In Q4 2021, Amortization of Deferred Charges rose 69.69% year-over-year to $24166.0; the TTM figure through Dec 2021 stood at $232000.0 (up 277.7% YoY), while the FY2022 annual figure was $328000.0, up 41.38% from the prior year.
  • Amortization of Deferred Charges was $24166.0 for Q4 2021 at Liquidia, down from $77816.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $124178.0 in Q1 2021 to a low of $5840.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 24,166.00
Dec 31, 2021 24,166.00
Sep 30, 2021 77,816.00
Sep 30, 2021 77,816.00
Jun 30, 2021 5,840.00
Jun 30, 2021 5,840.00
Mar 31, 2021 124,178.00
Mar 31, 2021 124,178.00
Dec 31, 2020 14,241.00
Dec 31, 2020 14,241.00
Sep 30, 2020 11,382.00
Sep 30, 2020 11,382.00
Jun 30, 2020 16,643.00
Jun 30, 2020 16,643.00
Mar 31, 2020 19,158.00
Mar 31, 2020 19,158.00